CTOs on the Move

Boston MicroFluidics

www.bostonmicrofluidics.com

 
Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Boston MicroFluidics raised $17.5M on 08/27/2019

Similar Companies

PL Developments

PL Developments is a Westbury, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Condensed Curriculum International Inc

Condensed Curriculum International Inc is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

S Epilepsy

S Epilepsy is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Swan Hospice

Swan Hospice is a healthcare provider that offers personalized end-of-life care plans for terminally ill adult patients and support for their families.

PRA Health Sciences

At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side by side with our clients, we strive to move drug discovery forward, helping develop life-saving and life-improving drugs. PRA has more than 10,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100 plus marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50 plus such drugs.